Can-Fite Biopharma Ltd.

Other

Famillion Ltd.

Ilan Cohn

Pnina Fishman

Dan Rolls

Iphtach Cohen

Tatiana Reitblat

Ilana Lorber

A method including entering individual-associated data bits (IDBs) into a computerized system, the set of data of each of the IDBs including at least one personal identifier of an individual and relationship data including data on one or more related individuals and the nature of the relationship, processing the entered IDBs on a processor, generating an individual-identifier data set (IDS) for each identified individual or one of the related individuals having data in the processed IDBs, and storing IDSs of identified individuals in a database.

Constructing a database of verified individuals

A system and method are presented for managing and using (e.g. for commercial or medical use) of a database. A verified database of a plurality of identified individuals is provided. The verified database comprises a plurality of individual-identifier data sets (IDSs) and relationship data. The verified database is processed in accordance with one or more parameters or conditions selected in accordance with at least one medical application, and a sub-group database is created including data records of the individuals from the verified database having said one or more selected parameters or conditions. This allows collection of data comprising the one or more selected parameters or conditions and delivery of at least part of the collected data to one or more users, and enables applying data from the verified database to provide personalized medicine service to at least one of the identified individuals.

Method and system for use of a database of personal data records

The present invention provides a method for treating dry eye condition in an individual comprising administrating to said individual an amount of Aadenosine receptor (AAR) agonist, the amount being effective to ameliorate symptoms of dry eye in the individual. In accordance with one embodiment, the dry eye condition is manifested by one or more ophthalmologic clinical symptoms selected from foreign body sensation, burning, itching, irritation, redness, eye pain, blurred vision, degraded vision and excessive tearing. A preferred ARAg in accordance with the invention is N-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (IB-MECA).

Treatment of dry eye conditions

Adenosine and active agent which interact with the adenosine system are used to treat conditions of weakened, immune system, as an anti-cancer therapy and for improving the therapeutic index of a variety of therapeutic drugs.

Method of treating leukopenia with adenosine

The present invention relates to a method of inducing proliferation of bone marrow cells in a subject, compromising administering to the subject an effective amount of an adenosine A1 receptor agonist. The present invention further relates to a method for preventing reduction in level of leukocytes in a subject as a result of a treatment comprising administering to the individual an effective amount of an adenosine A1 receptor agonist. In addition, the invention relates to a method of treatment of an individual comprising administering to the subject a therapeutic drug in combination with an adenosine A1 receptor agonist.

Growing community of inventors

Herzliya, Israel

Ilan Cohn